Differential effects of the tyrosine kinase inhibitors on collagen type 1-induced platelet aggregation and adhesion to this protein

Thrombosis Research

Volumn 86, Issue 4, 1997, Pages 287-299

  Kralisz, Urszula ^a   Cierniewski, Czeslaw S ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Adhesion; Aggregation; Platelets; Protein tyrosine kinases

Indexed keywords

CINNAMIC ACID DERIVATIVE; COLLAGEN TYPE 1; HERBIMYCIN A; LAVENDUSTIN A; PROTEIN KINASE P60; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOSIS;

BENZOQUINONES; CINNAMATES; COLLAGEN; CROSS-LINKING REAGENTS; DRUG SYNERGISM; HUMANS; LACTAMS, MACROCYCLIC; PHENOLS; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PROTEIN-TYROSINE KINASES; QUINONES;

EID: 0030797105     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00072-8     Document Type: Article

References (39)

1. FERRELL J.E, MARTIN G.S. Platelet tyrosine-specific protein phosphorylation is regulated by thrombin. Mol. Cell Biol. 8:1988;3603-3610.
2. GOLDEN A., BRUGGE J.S. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets. Proc. Natl. Acad. Sci. USA. 86:1989;901-905.
3. NAKAMURA S., YAMAMURA H. Thrombin and collagen induce rapid phosphorylation of a common set cellular proteins on tyrosine in human platelets. J. Biol. Chem. 264:1989;7089-7091.
4. SHIBATA K., NISHIMURA J., YUFU Y., NAWATA H. Alteration in thrombin-induced protein tyrosine phosphorylation of platelets from patients with chronic myelogenous leukemia. Int. J. Hematol. 55:1992;189-196.
5. c-src-specific tyrosine kinase activity. Proc. Natl. Acad. Sci. USA. 83:1986;852-856.
6. HUANG M.M., BOLEN J.B., BARNWELL J.B., SHATTIL S.J., BRUGGE J.S. Membrane glycoprotein IV (CD36) is physically associated with the fyn, lyn, and yes protein tyrosine kinases in human platelets. Proc. Natl. Acad. Sci. USA. 88:1991;7844-7848.
7. c-src from human platelets. J. Biol. Chem. 265:1990;8205-8211.
8. fyn in human platelets. Oncogene. 5:1990;597-602.
9. syk is activated by wheat germ agglutinin in platelets. Biochem. Biophys. Res. Commun. 185:1992;1128-1132.
10. NAKAMURA S., YANAGI S., YAMAMURA H. Purification and characterization of cytosolic protein tyrosine kinase from bovine platelets. Eur. J. Biochem. 174:1988;471-477.
11. FAK in platelets. J. Cell Biol. 119:1992;905-912.
12. c-src in human platelets. Oncogene. 5:1990;1033-1036.
13. FERRELL J.E., MARTIN G.S. Platelet tyrosine-specific protein phosphorylation is regulated by thrombin. Moll. Cell Biol. 8:1988;3603-3610.
14. HAIMOVICH B., LIPFERT L., BRUGGE J.S., SHATTIL S.J. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J. Biol. Chem. 268:1993;15868-15877.
15. syk in collagen-induced signal transduction in platelets. Eur. J. Biochem. 226:1994;243-248.
16. O. UEHARA Y., MURAKAMI M., MIZUNO S., KAWAI S. Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A. Virology. 164:1988;294-299.
17. CHANG Ch.J., GEAHLEN R.L. Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents. J. Natural Products. 55:1992;1529-1560.
18. UMWZAWA K., HORI K., TAJIMA H., IMOTO M., ISSHIKI K., TAKEUCHI T. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors. FEBS Lett. 260:1990;198-200.
19. AKIYAMA T., ISHIDA J., NAKAGAWA S., OGAWARA H., WATANABE S., ITOH N., SHIBUYA M., FUKAMI Y. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J. Biol. Chem. 262:1987;5592-5595.
20. DEAN N.M., KANEMITSU M., BOYTON A.L. Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells. Biochem. Biophys. Res. Commun. 165:1989;795-801.
21. TANDON N.N., KRALISZ U., JAMIESON G.A. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J. Biol. Chem. 264:1989;7576-7583.
22. WATALA C., PIETRUCHA T., GWOZDZINSKI K., KRALISZ U., CIERNIEWSKI CZ.S. Microenvironment changes in human blood platelet membranes associated with binding of tissue-type plasminogen activator. Eur. J. Biochem. 215:1993;867-871.
23. GOODNO C.C. Myosin active-site trapping with vanadate ion. Methods Enzymol. 85:1982;116-123.
24. 4. Nature. 227:1970;680-685.
25. O'SHEA J.J., MCVICAR D.V., BAILEY T.L., BURNS CH., SMYTH M.J. Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc. Natl. Acad. Sci. USA. 89:1992;10306-10310.
26. 2-mediated human platelet responses. Mol. Pharmacol. 39:1991;475-480.
27. 3(platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin polymers. J. Biol. Chem. 269:1994;32479-32487.
28. FAK. Biochem. J. 296:1993;543-547.
29. fak accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell Biol. 119:1992;893-903.
30. ONODA T., IINUMA H., SASAKI Y., HAMADA M., ISSHIKI K., NAGANAWA H., TAKEUCHI T. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from streptomyces griseolavendus. J. Natural Products. 52:1989;1252-1257.
31. SALARI H., DURONIO V., HOWARD S.L., DEMOS M., JONES K., REANY A., HUDSUN A.T., PELECH S.L. Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelet. FEBS Lett. 263:1990;104-108.
32. 2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J. Biol. Chem. 268:1993;18151-18156.
33. MCNICOL A. The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase. Prostaglandins Leukotriens and Essential Fatty Acids. 48:1993;379-384.
34. BEST L.C., HOLLAND T.K., JONES P.B.B., RUSSELL R.G.G. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. Thromb. Haemostas. 43:1980;38-40.
35. SMITH B.J., DANGELMAIER C. Determination of platelet adhesion to collagen and the associated formation of phosphatidic acid and calcium mobilization. Anal. Biochem. 187:1990;173-178.
36. BAUMGARTNER H.R., TSCHOP T.B., WEISS H.J. Platelet interaction with collagen fibrils in flowing blood. II. Impaired adhesion-aggregation in bleeding disorders. A comparison with subendothelium. Thromb. Haemostas. 37:1977;17-28.
37. MORIN R.J., CHEN A.F.T., NARAYANAN A.S., RAYE CH., MOSS R.A., SRIKANTOIAH M.V., BARAJAS L. Platelet adhesion to collagen in normal and von Willebrand's disease subjects. Thromb. Res. 17:1980;719-728.
38. SHADLE P.J., BARONDES S.H. Adhesion of human platelets to immobilized trimeric collagen. J. Cell Biol. 95:1982;361-365.
39. DOLOWY K., CUNNINGHAM L.W. Adhesion of human platelets to collagen: evidence for two states of platelet adhesion. Collagen Rel. Res. 4:1984;111-118.